Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Open267.540 | Close266.860 |
Vol / Avg.1.705M / 2.506M | Mkt Cap142.744B |
Day Range265.010 - 267.805 | 52 Wk Range211.710 - 296.630 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.490 | 5.000 | 0.5100 | ||||
REV | 6.680B | 6.986B | 306.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | Argus Research | David Toung | Maintains | BuyBuy | Raises | 260.00 | 280.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 320.00 |
2023-09-05 | Truist Securities | Robyn Karnauskas | Reiterates | HoldHold | Maintains | - | 260.00 |
2023-08-14 | Jefferies | Michael Yee | Maintains | BuyBuy | Raises | 275.00 | 310.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AMGN | Amgen | -0.31% | 142.7B |
LEGN | Legend Biotech | 0.36% | 11.6B |
EXAS | Exact Sciences | -1.36% | 11.9B |
SRPT | Sarepta Therapeutics | -4.33% | 10.7B |
NBIX | Neurocrine Biosciences | -0.05% | 11.1B |
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Argus Research on Monday, September 18, 2023. The analyst firm set a price target for 280.00 expecting AMGN to rise to within 12 months (a possible 4.92% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $266.86 last updated September 25, 2023 at 8:00 PM UTC.
A quarterly cash dividend of $2.13 per share of Class A Common Stock. The quarterly cash dividend was payable on September 8, 2023 to stockholders of record on August 17, 2023.
Amgen’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.